Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicentre, randomised, double-blind, controlled trial. Commentary
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 2008, Vol.372 (9638) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 9638 |
| container_start_page | |
| container_title | The Lancet (British edition) |
| container_volume | 372 |
| creator | SARAFIDIS, Pantelis A BAKRIS, George L BUDAJ, Andrzej CHAITHIRAPHAN, Suphachai DICKSTEIN, Kenneth KELTAI, Matyas METSARINNE, Kaj OTO, All PARKHOMENKO, Alexander PIEGAS, Leopoldo S SVENDSEN, Tage L TEO, Koon K MANN, Johannes F. E YUSUF, Salim SCHMIEDER, Roland E MCQUEEN, Matthew DYAL, Leanne SCHUMACHER, Helmut POGUE, Janice XINGYU WANG MAGGIONI, Aldo |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_20558141</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20558141</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_205581413</originalsourceid><addsrcrecordid>eNqNjs1KxDAUhYMoWEff4W4EhVZSJ23FnQyjrhSGLmY33LZ3bPQmKUmqzFv5iEbwAVwdDnzn50hkpWpUUalmeywyWSpZ1M2yPhVnIbxLKVUtq0x8b8gig5tj7wwF-NJxhEhsdEAf0ebg0ejJa87BeehcHHPQFiZyExNghFG_jfCJoZ8ZPXgdPuAqjgSvL-3D5mndQojzcLiGe0AwM0fdk42efovt4NIODTkMbu6Yio61Ta53iXDMNED0GvkGVs6YFEN_OBcne-RAF3-6EJeP63b1XEzpAvI-tfY67NJjk-jdrayqu1KVy_9yP3JcZFc</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicentre, randomised, double-blind, controlled trial. Commentary</title><source>Elsevier ScienceDirect Journals</source><creator>SARAFIDIS, Pantelis A ; BAKRIS, George L ; BUDAJ, Andrzej ; CHAITHIRAPHAN, Suphachai ; DICKSTEIN, Kenneth ; KELTAI, Matyas ; METSARINNE, Kaj ; OTO, All ; PARKHOMENKO, Alexander ; PIEGAS, Leopoldo S ; SVENDSEN, Tage L ; TEO, Koon K ; MANN, Johannes F. E ; YUSUF, Salim ; SCHMIEDER, Roland E ; MCQUEEN, Matthew ; DYAL, Leanne ; SCHUMACHER, Helmut ; POGUE, Janice ; XINGYU WANG ; MAGGIONI, Aldo</creator><creatorcontrib>SARAFIDIS, Pantelis A ; BAKRIS, George L ; BUDAJ, Andrzej ; CHAITHIRAPHAN, Suphachai ; DICKSTEIN, Kenneth ; KELTAI, Matyas ; METSARINNE, Kaj ; OTO, All ; PARKHOMENKO, Alexander ; PIEGAS, Leopoldo S ; SVENDSEN, Tage L ; TEO, Koon K ; MANN, Johannes F. E ; YUSUF, Salim ; SCHMIEDER, Roland E ; MCQUEEN, Matthew ; DYAL, Leanne ; SCHUMACHER, Helmut ; POGUE, Janice ; XINGYU WANG ; MAGGIONI, Aldo</creatorcontrib><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Lancet</publisher><subject>Biological and medical sciences ; General aspects ; Medical sciences</subject><ispartof>The Lancet (British edition), 2008, Vol.372 (9638)</ispartof><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20558141$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>SARAFIDIS, Pantelis A</creatorcontrib><creatorcontrib>BAKRIS, George L</creatorcontrib><creatorcontrib>BUDAJ, Andrzej</creatorcontrib><creatorcontrib>CHAITHIRAPHAN, Suphachai</creatorcontrib><creatorcontrib>DICKSTEIN, Kenneth</creatorcontrib><creatorcontrib>KELTAI, Matyas</creatorcontrib><creatorcontrib>METSARINNE, Kaj</creatorcontrib><creatorcontrib>OTO, All</creatorcontrib><creatorcontrib>PARKHOMENKO, Alexander</creatorcontrib><creatorcontrib>PIEGAS, Leopoldo S</creatorcontrib><creatorcontrib>SVENDSEN, Tage L</creatorcontrib><creatorcontrib>TEO, Koon K</creatorcontrib><creatorcontrib>MANN, Johannes F. E</creatorcontrib><creatorcontrib>YUSUF, Salim</creatorcontrib><creatorcontrib>SCHMIEDER, Roland E</creatorcontrib><creatorcontrib>MCQUEEN, Matthew</creatorcontrib><creatorcontrib>DYAL, Leanne</creatorcontrib><creatorcontrib>SCHUMACHER, Helmut</creatorcontrib><creatorcontrib>POGUE, Janice</creatorcontrib><creatorcontrib>XINGYU WANG</creatorcontrib><creatorcontrib>MAGGIONI, Aldo</creatorcontrib><title>Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicentre, randomised, double-blind, controlled trial. Commentary</title><title>The Lancet (British edition)</title><subject>Biological and medical sciences</subject><subject>General aspects</subject><subject>Medical sciences</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqNjs1KxDAUhYMoWEff4W4EhVZSJ23FnQyjrhSGLmY33LZ3bPQmKUmqzFv5iEbwAVwdDnzn50hkpWpUUalmeywyWSpZ1M2yPhVnIbxLKVUtq0x8b8gig5tj7wwF-NJxhEhsdEAf0ebg0ejJa87BeehcHHPQFiZyExNghFG_jfCJoZ8ZPXgdPuAqjgSvL-3D5mndQojzcLiGe0AwM0fdk42efovt4NIODTkMbu6Yio61Ta53iXDMNED0GvkGVs6YFEN_OBcne-RAF3-6EJeP63b1XEzpAvI-tfY67NJjk-jdrayqu1KVy_9yP3JcZFc</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>SARAFIDIS, Pantelis A</creator><creator>BAKRIS, George L</creator><creator>BUDAJ, Andrzej</creator><creator>CHAITHIRAPHAN, Suphachai</creator><creator>DICKSTEIN, Kenneth</creator><creator>KELTAI, Matyas</creator><creator>METSARINNE, Kaj</creator><creator>OTO, All</creator><creator>PARKHOMENKO, Alexander</creator><creator>PIEGAS, Leopoldo S</creator><creator>SVENDSEN, Tage L</creator><creator>TEO, Koon K</creator><creator>MANN, Johannes F. E</creator><creator>YUSUF, Salim</creator><creator>SCHMIEDER, Roland E</creator><creator>MCQUEEN, Matthew</creator><creator>DYAL, Leanne</creator><creator>SCHUMACHER, Helmut</creator><creator>POGUE, Janice</creator><creator>XINGYU WANG</creator><creator>MAGGIONI, Aldo</creator><general>Lancet</general><scope>IQODW</scope></search><sort><creationdate>2008</creationdate><title>Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicentre, randomised, double-blind, controlled trial. Commentary</title><author>SARAFIDIS, Pantelis A ; BAKRIS, George L ; BUDAJ, Andrzej ; CHAITHIRAPHAN, Suphachai ; DICKSTEIN, Kenneth ; KELTAI, Matyas ; METSARINNE, Kaj ; OTO, All ; PARKHOMENKO, Alexander ; PIEGAS, Leopoldo S ; SVENDSEN, Tage L ; TEO, Koon K ; MANN, Johannes F. E ; YUSUF, Salim ; SCHMIEDER, Roland E ; MCQUEEN, Matthew ; DYAL, Leanne ; SCHUMACHER, Helmut ; POGUE, Janice ; XINGYU WANG ; MAGGIONI, Aldo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_205581413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Biological and medical sciences</topic><topic>General aspects</topic><topic>Medical sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SARAFIDIS, Pantelis A</creatorcontrib><creatorcontrib>BAKRIS, George L</creatorcontrib><creatorcontrib>BUDAJ, Andrzej</creatorcontrib><creatorcontrib>CHAITHIRAPHAN, Suphachai</creatorcontrib><creatorcontrib>DICKSTEIN, Kenneth</creatorcontrib><creatorcontrib>KELTAI, Matyas</creatorcontrib><creatorcontrib>METSARINNE, Kaj</creatorcontrib><creatorcontrib>OTO, All</creatorcontrib><creatorcontrib>PARKHOMENKO, Alexander</creatorcontrib><creatorcontrib>PIEGAS, Leopoldo S</creatorcontrib><creatorcontrib>SVENDSEN, Tage L</creatorcontrib><creatorcontrib>TEO, Koon K</creatorcontrib><creatorcontrib>MANN, Johannes F. E</creatorcontrib><creatorcontrib>YUSUF, Salim</creatorcontrib><creatorcontrib>SCHMIEDER, Roland E</creatorcontrib><creatorcontrib>MCQUEEN, Matthew</creatorcontrib><creatorcontrib>DYAL, Leanne</creatorcontrib><creatorcontrib>SCHUMACHER, Helmut</creatorcontrib><creatorcontrib>POGUE, Janice</creatorcontrib><creatorcontrib>XINGYU WANG</creatorcontrib><creatorcontrib>MAGGIONI, Aldo</creatorcontrib><collection>Pascal-Francis</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SARAFIDIS, Pantelis A</au><au>BAKRIS, George L</au><au>BUDAJ, Andrzej</au><au>CHAITHIRAPHAN, Suphachai</au><au>DICKSTEIN, Kenneth</au><au>KELTAI, Matyas</au><au>METSARINNE, Kaj</au><au>OTO, All</au><au>PARKHOMENKO, Alexander</au><au>PIEGAS, Leopoldo S</au><au>SVENDSEN, Tage L</au><au>TEO, Koon K</au><au>MANN, Johannes F. E</au><au>YUSUF, Salim</au><au>SCHMIEDER, Roland E</au><au>MCQUEEN, Matthew</au><au>DYAL, Leanne</au><au>SCHUMACHER, Helmut</au><au>POGUE, Janice</au><au>XINGYU WANG</au><au>MAGGIONI, Aldo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicentre, randomised, double-blind, controlled trial. Commentary</atitle><jtitle>The Lancet (British edition)</jtitle><date>2008</date><risdate>2008</risdate><volume>372</volume><issue>9638</issue><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><cop>London</cop><pub>Lancet</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 2008, Vol.372 (9638) |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_pascalfrancis_primary_20558141 |
| source | Elsevier ScienceDirect Journals |
| subjects | Biological and medical sciences General aspects Medical sciences |
| title | Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicentre, randomised, double-blind, controlled trial. Commentary |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T15%3A19%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Renal%20outcomes%20with%20telmisartan,%20ramipril,%20or%20both,%20in%20people%20at%20high%20vascular%20risk%20(the%20ONTARGET%20study)%20:%20a%20multicentre,%20randomised,%20double-blind,%20controlled%20trial.%20Commentary&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=SARAFIDIS,%20Pantelis%20A&rft.date=2008&rft.volume=372&rft.issue=9638&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E20558141%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |